Cargando…

Botox, Migraine, and the American Academy of Neurology: An Antidote to Anecdote

Detalles Bibliográficos
Autores principales:	Jackson, Mark, Barbuto, John P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2008
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438143/ https://www.ncbi.nlm.nih.gov/pubmed/18597576 http://dx.doi.org/10.18553/jmcp.2008.14.5.465

Ejemplares similares

Interpreting Hazards: The Increasing Importance of Antidote to Anecdote in Managed Care
por: Fairman, Kathleen A.
Publicado: (2010)

Dispute settlement understanding on the use of BOTOX(®) in chronic migraine
por: Martelletti, Paolo
Publicado: (2011)

An antidote for Staphylococcus aureus pneumonia?
por: DeLeo, Frank R., et al.
Publicado: (2008)

Beyond Beauty: Onobotulinumtoxin A (BOTOX®) and the Management of Migraine Headaches
por: Becker, Devra, et al.
Publicado: (2012)

Advanced anecdotes in American English
por: Hill, L. A. (Leslie Alexander)
Publicado: (1981)

Botox (OnabotulinumtoxinA) for Treatment of Migraine Symptoms: A Systematic Review
por: Shaterian, Negar, et al.
Publicado: (2022)

Treatment of chronic migraine with Botox (onabotulinumtoxinA): Development, insights, and impact
por: Turkel, Catherine C., et al.
Publicado: (2023)

Creativity as an antidote to research becoming too predictable
por: Baer, Markus, et al.
Publicado: (2023)

COVID-19 Pandemic: The response of the American academy of neurology
por: Stevens, James
Publicado: (2021)

Experience with onabotulinumtoxinA (BOTOX) in chronic refractory migraine: focus on severe attacks
por: Oterino, A., et al.
Publicado: (2011)

There is Value in Anecdotal Reports of Relief from Migraine with Botulinum Toxin
por: Winett, Bill
Publicado: (2009)

Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway
por: Hansson-Hedblom, Amanda, et al.
Publicado: (2020)

Antidotes, antibody-mediated immunity and the future of pharmaceutical product development
por: Caoili, Salvador Eugenio C.
Publicado: (2013)

Potassium Permanganate as an Antidote to the Venom of Serpents: A Note Communicated to the French Academy
por: DeLacerda, M.
Publicado: (1882)

Anecdote of an Insane Clergyman before the American Revolution
Publicado: (1847)

Location, Location, Location: an Antidote That Both Activates and Neutralizes a Toxin Used in Bacterial Warfare
por: Ahmad, Shehryar, et al.
Publicado: (2023)

How to block botox
por: Dove, Alan W.
Publicado: (2003)

Role of botox in BPBP
por: Bhardwaj, Praveen
Publicado: (2015)

The Neurological Institute of New York 1909–1974, with personal anecdotes
Publicado: (1977)

Hull prospective analysis of Botulinum Toxin type A (Botox) use in the treatment of chronic migraine
por: Ahmed, F, et al.
Publicado: (2013)

Anecdotical
Publicado: (1855)

Consequences of neurologic lesions assessed by Barthel Index after Botox(®) injection may be underestimated
por: Dionyssiotis, Y, et al.
Publicado: (2012)

EHMTI-0223. Botox in the prevention of chronic migraine; 18-months follow up outcome in 67 patients
por: Khalil, M, et al.
Publicado: (2014)

Anatomical Regional Targeted (ART) BOTOX Injection Technique: A Novel Paradigm for Migraines and Chronic Headaches
por: Amirlak, Bardia, et al.
Publicado: (2016)

Depression and Just What I Thought
por: Barbuto, John P.
Publicado: (2008)

Antidotes in Poisoning
por: Chacko, Binila, et al.
Publicado: (2019)

Antidotes
Publicado: (1844)

Why the American Academy of Pediatrics recommends initiating HPV vaccine at age 9
por: O’Leary, Sean T.
Publicado: (2022)

Anecdotes of Desgeneltes
Publicado: (1863)

Medical Anecdotes
Publicado: (1804)

Biographical Anecdotes
Publicado: (1783)

Homœopathia.—Anecdote
Publicado: (1850)

An Anecdote of Waterloo
Publicado: (1882)

Just an anecdote
por: Koppenburg, Patrick
Publicado: (2021)

Optical anecdotes
por: Lovell, DJ
Publicado: (2004)

Anatomical Regional Targeted (ART) BOTOX Injection Technique: A Novel Paradigm for Migraines and Chronic Headaches: Erratum
Publicado: (2017)

Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines
por: Siddiqui, Mariah, et al.
Publicado: (2021)

American Academy of Medicine
por: Dunglison, Richard J.
Publicado: (1883)

The American Academy of Medicine
Publicado: (1894)

The American Academy of Medicine
Publicado: (1878)

Cannot write session to /tmp/vufind_sessions/sess_4msgam3r545hvv62pb7m7h8b3l